Laddar...
Salmeterol/fluticasone combination in the treatment of COPD
Clinical trials of a combination therapy of an inhaled corticosteroid, fluticasone propionate (FP), with a long-acting β(2)-agonist, salmeterol (Sal), have demonstrated a greater improvement in lung function and in quality of life measures after the combination compared with either component of alon...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2006
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2707153/ https://ncbi.nlm.nih.gov/pubmed/18046860 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|